Over the latest trailing 12-month period, total return cagr is +454.84%. The comparable SPY value is +18.54%. Year-to-date total return is +359.85%. Total return includes price appreciation and reinvested dividends.
Growth of $10,000 in MRNA
$72,909
(7.3x return)
Invested on Dec 7, 2018
Growth of $10,000 in SPY (S&P 500)
$32,546
(3.3x return)
Invested on Dec 7, 2018
This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.
YTD Total Return
+359.9%
1-Year Total Return
+454.2%
Current Dividend Yield
N/A
Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.
| Holding Period | Price CAGR | Total Return CAGR | Dividend Addition |
|---|---|---|---|
| 1 Year | +454.8% | +454.8% | N/A |
| 3 Years | +8.0% | +8.0% | N/A |
| 5 Years | (21.5%) | (21.5%) | N/A |
| 10 Years | N/A | N/A | N/A |
| 15 Years | N/A | N/A | N/A |
| 20 Years |
| N/A |
| N/A |
| N/A |
